1 / 70

Modelling and Simulation – M & S

Modelling and Simulation in Health Technology – from Development via Implementation to Assessment F. Breitenecker, Vienna Univ. of Technology Niki Popper, dwh Simulation Sevices Siegfried Wassertheurer, Austrian Inst. of Technology. Modelling and Simulation – M & S.

sofia
Download Presentation

Modelling and Simulation – M & S

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Modelling and Simulation in Health Technology – from Development via Implementation to AssessmentF. Breitenecker, Vienna Univ. of Technology Niki Popper, dwh Simulation Sevices Siegfried Wassertheurer, Austrian Inst. of Technology

  2. Modelling and Simulation – M & S • Modelling and Simulation – Technique since 1970 • 3rd Pillar of Science Theory Problem Simulation Solution Abstraktion der Realität Experiment

  3. Theory Problem Simulation Solution Experiment Modelling and Simulation – M & S • Modelling and Simulation – Technique since 1970 • 3rd Pillar of Science • Problem Solution

  4. Theory Problem Simulation Solution Experiment Modelling and Simulation – M & S • Modelling and Simulation – Technique since 1970 • 3rd Pillar of Science • Problem Solution • Aim and Goal ?

  5. Theory Problem Simulation Solution Experiment Modelling and Simulation – M & S • Modelling and Simulation – Technique since 1970 • 3rd Pillar of Science • Problem Solution • Aim and Goal ? Simulation is the process of designing a model of a real system and conducting experiments with this model for the purpose either of understanding the behavior of the system and its underlying causes or of evaluating various designs of an artificial system or strategies for the operation of the system.

  6. Theory Problem Simulation Solution Experiment Modelling and Simulation – M & S • Modelling and Simulation – Technique since 1970 • 3rd Pillar of Science • Problem Solution • Aim and Goal • Level of Application / Use

  7. Theory Problem Simulation Solution Experiment Modelling and Simulation – M & S • Modelling and Simulation – Technique since 1970 • 3rd Pillar of Science • Problem Solution • Aim and Goal • Level of Application / Use DEVELOPMENT - IMPLEMENTATION - DIFFUSION

  8. PTS PTS PTS PTS PTS PTS PTS PTS PTS PTS Modelling and Simulation – M & S DEVELOPMENT - IMPLEMENTATION - DIFFUSION of a Product / Technique / Strategy (PTS) PTS

  9. PTS PTS PTS PTS PTS PTS PTS PTS PTS Modelling and Simulation – M & S DEVELOPMENT - IMPLEMENTATION - DIFFUSION of a Product / Technique / Strategy (PTS) PTS PTS M & S

  10. PTS PTS PTS PTS PTS PTS PTS PTS PTS Modelling and Simulation – M & S DEVELOPMENT - IMPLEMENTATION - DIFFUSION of a Product / Technique / Strategy (PTS) PTS PTS M & S M & S

  11. PTS PTS PTS PTS PTS PTS PTS PTS PTS Modelling and Simulation – M & S DEVELOPMENT - IMPLEMENTATION - DIFFUSION of a Product / Technique / Strategy (PTS) PTS PTS M & S M & S M & S

  12. Modelling and Simulation – M & S DEVELOPMENT - IMPLEMENTATION - DIFFUSION of a Product / Technique / Strategy (PTS) M & S M & S

  13. Modelling and Simulation – M & S DEVELOPMENT - IMPLEMENTATION - DIFFUSION of a Product / Technique / Strategy (PTS) Em-bedded M&S M & S Mechatronic M&S

  14. Modelling and Simulation – M & S DEVELOPMENT - IMPLEMENTATION - DIFFUSION of a Product / Technique / Strategy (PTS) Em-bedded M&S M & S ? Mechatronic M&S

  15. Modelling and Simulation – M & S DEVELOPMENT - IMPLEMENTATION - DIFFUSION DIFFUSION – Assessment at Free Market M & S

  16. Modelling and Simulation – M & S DEVELOPMENT - IMPLEMENTATION - DIFFUSION DIFFUSION – Assessment at Free Market M & S

  17. Modelling and Simulation – M & S DEVELOPMENT - IMPLEMENTATION - DIFFUSION DIFFUSION – Assessment at Free Market M & S

  18. Modelling and Simulation – M & S DEVELOPMENT - IMPLEMENTATION - DIFFUSION DIFFUSION – Assessment at Free Market

  19. Modelling and Simulation – M & S DEVELOPMENT - IMPLEMENTATION - DIFFUSION DIFFUSION – Assessment at Free Market Market M & S

  20. Modelling and Simulation – M & S ASSESSMENT DIFFUSION DEVELOPMENT - IMPLEMENTATION - of a Product / Technique / Strategy (PTS) Em-bedded M&S Market M & S MECHATRONICS Mechatronic M&S

  21. Modelling and Simulation – M & S ASSESSMENT DIFFUSION DEVELOPMENT - IMPLEMENTATION - Em-bedded M&S Market M & S MECHATRONICS Mechatronic M&S

  22. Modelling and Simulation – M & S ASSESSMENT DIFFUSION DEVELOPMENT - IMPLEMENTATION - Embedded M&S Embedded M&S HEALTH TECHNOLOGY M & S M&S

  23. Modelling and Simulation – M & S HEALTH TECHNOLOGY DEVELOPMENT - IMPLEMENTATION - DIFFUSION - ASSESSMENT Limited Market Controlled Market (Laws) Health Care Systems Use depends on Assessment ASSESSMENT - > DIFFUSION M & S

  24. Modelling and Simulation – M & S ASSESSMENT DIFFUSION DEVELOPMENT - IMPLEMENTATION - HEALTH TECHNOLOGY Embedded M&S Embedded M&S M&S with Markov – ODE – PDE - CA - AB - NN

  25. Modelling and Simulation – M & S Cardiovascular RiskStratificationandTherapy Optimization in Epidemiology using Simulation

  26. The arterialsystem in (technical) terms • Single source (heart) • Branched elasitc tubes for blood transport (arteries) • Various sinks (organs) • Unsteady pressure gradients drive the system • Arterial pressures (systolic/diastolic) are actually the most important inidactors in prevention/treatment

  27. Pathology (Hypertension)

  28. Costs Source: Austrian Social Insurance (1999-2004)

  29. Outcome • Only 10-15 % of treated patients reach their therapy goals within OECD countries! (Source: WHO, AHA) • Vienna Study • 7100 Probands • 50 % Hypertensives • 1110 in treatment • 185 (16%) well treated!

  30. 1 Paradox – 2 Answers Only 50 % CHD are related to Hypertension?!

  31. Circadian Blood Pressure • 24 h Blood pressure profile • White coat hypertension • Masked hypertension Blood Pressure is time dependent!

  32. Explanation Blood pressure depends on the arterial site!

  33. Howto handle? Dynamics! Womersley Solution for Navier-Stokes Eq.

  34. Generalized Transfer Function (GTF) This approach allows for the first time widespread epidemiological use!

  35. Ambulatory Pulse Wave Analysis

  36. Validation

  37. Example 1: Physiological Case

  38. Example 2:Non-Dipper

  39. Example 3:Raiser

  40. Modelling and Simulation – M & S META – LEVEL: „SIMULATION ON THE MARKET“ – Health Technology ZEBRAS

  41. Modelling and Simulation – M & S META – LEVEL: „SIMULATION ON THE MARKET“ HEALTH TECHNOLOGY ASSESSMENT – Using Simulation - Competitor NN DT MC CA SD DE PM AB DEVs

  42. Modelling and Simulation – M & S META – LEVEL: „SIMULATION ON THE MARKET“ DIFFERENT (EASIER) APPLICATION

  43. DEMANDS: EASY TO USE

  44. Σ

  45. Modelling and Simulation – M & S META – LEVEL: „SIMULATION ON THE MARKET“ HEALTH TECHNOLOGY ASSESSMENT – Using Simulation - Competitors DT MC CA SD DE PM AB DEVs NN

  46. Modelling and Simulation – M & S META – LEVEL: „SIMULATION ON THE MARKET“ HEALTH TECHNOLOGY ASSESSMENT – Using Simulation - Competitors DT MC CA SD DE PM AB DEVs NN

  47. Modelling and Simulation – M & S HEALTH TECHNOLOGY ASSESSMENT Evaluation = Evidence Based Decision Making For Effective and Efficient Use of Ressources YES: Do not things without Benefit – “Make it Rational” NO: Deprive things with Benefit – “Rationalise”

  48. Dissociation of Prooved Benefit of Costs for Medical Care

  49. Modelling and Simulation – M & S M&S IN HEALTH TECHNOLOGY ASSESSMENT Problem 1: Goal Function - LYG, QLYG, ...

More Related